logo
15:57 Dec 05

Windlas Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
769.40
-20.75 (-2.63%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Windlas Biotech Ltd. Financials

Windlas Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
769.40
-20.75 (-2.63%)
15:57 Dec 05
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

6

Weakness

5

Opportunity

0

Threats

1

11.95 %

ROE %

7.94 %

ROA %

32.12

EPS

241.30

BVPS

7.95 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
465.93 513.08 630.96 759.88 794.81
Operating Expenses +
413.5 452.86 552.79 665.78 695.07
Raw Material
307.56 340.71 386.59 493.38 502.61
Increase Decrease in Cost
-4.74 -15.27 9.59 -21.52 -10.42
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
63.41 70.32 87.46 122.92 127.3
Miscellaneous Expenses
47.27 57.1 69.15 71 75.58
Operating Profit
52.43 60.22 78.17 94.1 99.74
Other Income
6.71 9.96 13.47 18.02 19.13
Depreciation
12.15 12.36 13.44 27.98 29.23
Interest
1.42 0.79 1.1 4.38 4.95
Profit before tax and exceptio..
45.56 57.04 77.09 79.76 84.69
Exceptional Items
0 0 0 0 0
PBT
45.56 57.04 77.09 79.76 84.69
Provision for Taxation
7.48 14.41 18.9 18.76 19.52
Net Profit
38.09 42.63 58.19 60.99 65.18
NET Profit after MI
38.09 42.63 57.94 60.44 65.18
EPS
18.58 19.7 27.97 28.87 31.14
Operating Profit Margin (%)
11.25 11.74 12.39 12.38 12.55
Net Profit Margin (%)
8.18 8.31 9.18 7.95 8.2

Windlas Biotech Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 62.00 62.30 62.30 62.50 62.50 62.50
FII 1.10 1.40 1.50 1.60 2.00 1.60
Public 11.50 11.30 10.90 10.20 9.60 10.30
Others 25.40 25.00 25.30 25.70 25.90 25.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: